Springbok

Company profile

About Springbok

Springbok Analytics is a medical imaging technology company that specializes in AI-powered muscle health quantification using MRI data. The company's FDA-cleared MuscleView 2.0™ platform transforms standard MRI scans into detailed 3D visualizations and comprehensive muscle-level analytics, measuring over 100 individual muscles across the legs, core, back, chest, shoulders, and arms. Springbok provides objective, validated metrics including muscle volume, fat infiltration, symmetry, and structural balance at the individual muscle level—far beyond traditional body composition estimates. The platform serves three primary markets: research and clinical trials, where it accelerates drug development and provides validated imaging endpoints; elite sports and performance, where it tracks athlete-specific muscle data to guide return-to-play decisions and optimize training; and longevity and preventive health, where it enables personalized health strategies through objective muscle health tracking over time. The company's technology processes MRI scans within 24 hours and delivers detailed reports within 2-3 days through an interactive web-based viewer. Founded by Dr. Silvia Blemker as Chief Scientific Officer, Springbok's AI-driven approach provides reproducible, site-agnostic analysis that minimizes manual variability. The platform supports lower extremity scans (under 15 minutes) and full-body scans (under one hour) using standard, widely available MRI sequences. With comprehensive musculoskeletal databases for population benchmarking and compliance with FDA, GDPR, ISO, and SOC 2 standards, Springbok delivers the precision, speed, and regulatory confidence required for large-scale research, clinical trials, and performance optimization.

Company description · Springbok official website